These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2869951

  • 1. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L, Frithz G.
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M, Inagaki Y, Iimura O, Kuramoto K, Takeda T.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [Abstract] [Full Text] [Related]

  • 3. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R, Maclean D, Ioannides C, Johnston A, McDevitt DG.
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [Abstract] [Full Text] [Related]

  • 4. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L, Frithz G.
    J Cardiovasc Pharmacol; 1986 Jul; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [Abstract] [Full Text] [Related]

  • 5. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET).
    Haasis R, Bethge H.
    Eur Heart J; 1987 Dec; 8 Suppl M():103-13. PubMed ID: 2967183
    [Abstract] [Full Text] [Related]

  • 6. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R, Neff J, Heintz B, Nemeth N, Rahlfs VW, Nelson K.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ, Esper RC, Burrieza OH, Menna J.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [Abstract] [Full Text] [Related]

  • 8. Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker.
    Dahlöf B, Sjöberg KH, Flygt C, Jern S, Hansen S, Hansson L.
    J Cardiovasc Pharmacol; 1986 Dec; 8(1):55-9. PubMed ID: 2419693
    [Abstract] [Full Text] [Related]

  • 9. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H.
    Cardiology; 2006 Dec; 106(4):199-206. PubMed ID: 16679760
    [Abstract] [Full Text] [Related]

  • 10. Dose response studies of bevantolol in hypertensive patients.
    Okawa KK.
    Angiology; 1986 Mar; 37(3 Pt 2):233-8. PubMed ID: 2871783
    [Abstract] [Full Text] [Related]

  • 11. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS, Thomas P, Sheridan DJ.
    Eur J Clin Pharmacol; 1990 Mar; 38(1):21-4. PubMed ID: 1970298
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H, Selinus I, Hosie J, Frithz G, Weiner L.
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR, Berglund G, Anderson OK, Brunner HR, Scherrer U, van Brummelen P, Distler A, Philipp T, Fogari R, Mimran A.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.
    Frithz G, Weiner L.
    Eur J Clin Pharmacol; 1987 Dec; 32(1):77-80. PubMed ID: 2884116
    [Abstract] [Full Text] [Related]

  • 16. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B, Borst U, Gerhards W, Wagner G.
    Eur J Clin Pharmacol; 1989 Dec; 36(3):217-22. PubMed ID: 2568261
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E, Wagner G, vd Ven LL, Lie KI.
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS, Khurmi NS, Kardash MM, Hughes LO, Lahiri A, Raftery EB.
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.